Learn how the ZE5 Cell Analyzer advances the understanding of COVID-19
In this webinar, Dr Richard Cuthbert reviews how the ZE5 Cell Analyzer has been used in the fight against COVID-19. He discusses advances in the understanding of the disease and how flow cytometry is being used to develop new treatments. Finally, he highlights why Bio-Rad’s ZE5 Cell Analyzer is particularly suited for applications such as screening, antibody discovery, and vaccine development.
Topics covered:
- The phases of disease progression
- Prognostic factors ‒ lymphopenia and patient symptoms
- T-cell polarization and responses
- Treatments and antibody screens
Find out why the ZE5 Cell Analyzer is the right tool for this research.
Dr Richard Cuthbert,
Flow Cytometry Specialist, Life Science Group at Bio-Rad
Richard graduated with a Bachelor of Science in Biomedical Chemistry in 2000, and obtained his PhD in regenerative medicine at the University of Leeds in 2014. He was a Post-Doctoral Researcher at the University of Leeds from 2014-2019, where his primary research interests were stem cell biology, rheumatology, and immunology. He joined Bio-Rad as a Regional Flow Cytometry Specialist in 2019.